ICU Medical, Inc. ICUI
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.59% | 4.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.59% | 4.05% | |||
| Cost of Revenue | 0.17% | 3.56% | |||
| Gross Profit | 3.79% | 4.81% | |||
| SG&A Expenses | 1.64% | -1.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.41% | 2.06% | |||
| Operating Income | 16.05% | 36.70% | |||
| Income Before Tax | 30.14% | 670.86% | |||
| Income Tax Expenses | 1.74% | 120.37% | |||
| Earnings from Continuing Operations | 40.66% | -36.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.66% | -36.66% | |||
| EBIT | 16.05% | 36.70% | |||
| EBITDA | 7.29% | 13.35% | |||
| EPS Basic | 40.62% | -37.25% | |||
| Normalized Basic EPS | -4.23% | 133.55% | |||
| EPS Diluted | 40.79% | -36.67% | |||
| Normalized Diluted EPS | -4.58% | 137.08% | |||
| Average Basic Shares Outstanding | 0.03% | 0.95% | |||
| Average Diluted Shares Outstanding | 0.40% | -0.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||